Tailored solutions for each of your therapeutic needs.

From a blood test, the HLA typing requested in a healthy subject identifies comorbidities, that is to say, disease predispositions inherited from the parental genetic baggage (innate immunity). These can be autoimmune, degenerative, hematological, or cancerous pathologies.

The predictive diagnosis offered by the DIGITHLA platform can have a preventive orientation, justifying environmental, nutritional measures or drug or vaccine evictions.

The HLA haplotype is a specific marker of an active disease, produced by a set of inflammatory and/or infectious cascades that generate a morbid clinical state of immune dysregulation and degeneration.

The DIGITHLA platform identifies the specific and individual diagnostic and evolutionary probability for your patient.

The interconnection of the HLA system is the site of (1) specific reactivity to metals in the mouth, (2) any occlusal dysfunction that may be remotely related to somatic, immune, neurodegenerative, cancerous, and hematological pathologies, (3) specific immune reactivity of the periodontium in response to viral aggression, changes in oral microbiota, heavy metals, hormones, and diet.

The list of molecular mimicries proposed by DIGITHLA prevents rejections and other problems related to the immune system.

Need personalized advice ?

Healthcare professionals who wish to do so can benefit from additional expertise in the form of a detailed interpretation, more precise than that automatically performed by the DIGITHLA software platform.

Who is the HLA diagnosis for?

Only a doctor is authorized to prescribe a complete HLA system. They are also the only ones who can access the DIGITHLA software (in accordance with articles R.1131-4 and R.1131-5 of the public health code, and referring to the decree n°2008-321 of April 4, 2008 – order of May 27, 2013).

Individuals who wish for a detailed interpretation of their HLA system must therefore approach their doctor.

At the heart of our work


The HLA system is the tissue histocompatibility system that differentiates us into 10 subgroups called alleles, the combination of which forms a genetic map called the HLA Haplotype.

The HLA system was first used in the context of transplants to assess compatibility, which helps reduce graft rejection.

Currently, this system is a fundamental tool in population immunology and medical anthropology.


The digitHLA software platform catalogs all comorbidities linked to alleles and automatically narrows down this list by taking into account the medical history and a daily life questionnaire.

A detailed analysis of the digitHLA results by an expert can reduce the final list of comorbidities to just a few items.

Our platform

Easy to use, secure, accessible via the internet 24/7, it allows the automatic generation of reports (in PDF format) including:

explanations on the links between comorbidities and alleles,

the list of molecular mimicries (viral, bacterial, xenobiotic, and associated with heavy metals),

suitable therapeutic orientations.